Physician profile
Keith Alan Heier
NPI 1821013020
$1,027,303.58
in general payments reported to CMS, 2019-2025
20 companies · $76K in 2025
The $76K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $59K · 2021: $90K · 2022: $518K · 2023: $154K · 2024: $74K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $204K · Acquisitions: $57K · Consulting Fee: $28K · Travel and Lodging: $5,801 · Grant: $5,000 · Food and Beverage: $3,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $204,315.45 |
| Acquisitions | $56,652.57 |
| Consulting Fee | $27,870.34 |
| Travel and Lodging | $5,800.67 |
| Grant | $5,000.00 |
| Food and Beverage | $3,909.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $695,394.88 | 2022-2025 | 5ms, Colink Mini, Fracture and Correction Colag 2 |
| In2bones USA, LLC | $288,645.03 | 2019-2022 | |
| 4web, INC. | $19,041.89 | 2021-2023 | Osteotomy Truss System |
| International Life Sciences | $8,015.75 | 2022-2024 | Flexband |
| Theramicro, INC. | $6,162.01 | 2025 | Tekbrace Solo |
| Restor3d, INC. | $3,396.00 | 2023-2025 | |
| Pylant Medical | $2,276.28 | 2019-2025 | |
| Vilex LLC | $1,437.92 | 2025 | Hintermann, Dynex |
| Stryker Corporation | $1,313.35 | 2021-2025 | Infinity, Infinity Adaptis, Axs Infinity Ls |
| Wright Medical Technology, INC. | $574.15 | 2019 | |
| Bioventus LLC | $525.20 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Medartis INC. | $129.18 | 2022 | |
| Xtant Medical INC | $126.07 | 2023 | |
| Zimmer Biomet Holdings, INC. | $80.96 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $67.64 | 2022-2025 | Iovera, Exparel, Zilretta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $47.45 | 2019-2023 | Trinity Elite |
| Treace Medical Concepts, INC. | $29.63 | 2025 | |
| Horizon Therapeutics Plc | $20.35 | 2019 | |
| Medline Industries Lp | $19.84 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,432,756.17 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Heier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.